As policymakers in the US and abroad grapple with how to respond to the ongoing Zika virus outbreak, IDSA is making the case for having a robust, sustainable public health and medical research infrastructure in place to respond to any outbreak or emerging infection.
IDSA has joined with other groups in recent weeks in urging Congress to immediately advance President Obama’s request for $1.9 billion in emergency supplemental funding to address the Zika virus, both in Zika endemic countries and within the United States. In support of the federal response, IDSA has participated in congressional visits, White House strategy meetings, and a stakeholder summit held by the Centers for Disease Control and Prevention (CDC). The requested funding would increase global as well as domestic capacity for surveillance, as well as expand the Field Epidemiology Training Program, laboratory testing, and healthcare provider training. The supplemental funding would also accelerate research and development for medical countermeasures, including vaccines and diagnostics. In the absence of congressional action, the administration has redirected about $500 million from Ebola efforts to respond to the Zika outbreak, but these resources are insufficient and threaten to undermine responses to ongoing Ebola outbreaks in affected countries.
Visit IDSA’s Action Center
to join efforts to advocate for funding to address Zika and other infectious disease threats.
Global Backgrounders on Zika, Ebola
The IDSA Center for Global Health Policy has developed papers on the history, impacts and responses to Zika and Ebola. The Zika paper
(PDF) provides facts surrounding the current outbreak, with background and current information on data, findings, research needs and responses while the Ebola paper
(PDF) provides background and the present status of the West Africa Ebola outbreak that began at the end of 2013, and continues in episodic flare-ups in the three most affected countries: Guinea, Liberia and Sierra Leone. The papers are the first in a series the Global Center is developing to help IDSA members inform policymakers and opinion-shapers about the impacts of the diseases and the efforts needed to mount and sustain effective responses.
Guidance for Clinicians
IDSA continues to update its Zika Guidance web page
, which provides a summary of the clinical aspects, diagnostics and treatment of Zika as well as current CDC advisories regarding the outbreak. For more information on Ebola, see IDSA’s Ebola Resources
IDSA offers two email services to help members stay informed of updates from FDA and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. To subscribe, please click here
(member log-in required).